Catalent
A Principal Scientist in Process Development leads the development and implementation of mammalian cell culture upstream processing methodologies for therapeutic protein production. The role involves executing complex process development activities, including scale-up and optimization using Design of Experiments, while supporting technology transfer to cGMP manufacturing. Acting as a technical lead across multiple projects, the individual collaborates cross-functionally and with external clients to ensure robust and scalable process delivery.
Headquarters
Tampa, Florida, United States
Company Size
10001+ employees
Founded
2007
Catalent delivers end-to-end pharma solutions as a trusted CDMO, advancing drug development and manufacturing worldwide. Partner with us today!
Novo's troubled Indiana plant claims another victim as FDA rejects Incyte's lung cancer application
3 days ago
Inspection issues remain at Catalent Indiana plant, pharma companies say
1 day ago
Incyte’s Lung Cancer Expansion Bid Thwarted by Issues at Novo’s Catalent-Acquired Site
3 days ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Catalent.
Catalent didn’t post a salary, so this is our estimate from similar listings.
49% above the average for this role
Catalent to lay off at least 96 employees in Maryland amid ongoing workforce reductions
3 weeks ago
Upstream Process Development Lead
Pfizer
Upstream Senior Research Scientist
Elanco
BioProcess Engineer II, Upstream
ImmunityBio
Senior Scientist, Upstream Processing
Novartis
Associate Scientific Director / Principal Scientist — Cell Line Development and Upstream Protein Production
Syngene International Limited
Scientist, Upstream Process Development
Meridian Bioscience, Inc.